Iodamide Meglumine
This is an iodinated contrast agent used for X-ray imaging of body cavities and blood vessels. The meglumine salt form improves its tolerability compared to sodium salts and reduces toxicity. Like other iodinated contrast agents, it may cause allergic reactions or kidney stress and requires careful screening of patients.
Peso molecular
823,2000 g/mol
TPSA
209,00 Ų
Mecanismo de acción
Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.
Estructura 2D
Cite this structure
Embed this structure
SMILES
CC(=O)NCc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
InChI
InChI=1S/C12H11I3N2O4.C7H17NO5/c1-4(18)16-3-6-8(13)7(12(20)21)10(15)11(9(6)14)17-5(2)19;1-8-2-4(10)6(12)7(13)5(11)3-9/h3H2,1-2H3,(H,16,18)(H,17,19)(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1
Molecular Formula
C19H28I3N3O9
HBD / HBA
9 / 10
Enlaces Rotables
10
Átomos Pesados
34
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
This is an iodinated contrast agent used for X-ray imaging of body cavities and blood vessels. The meglumine salt form improves its tolerability compared to sodium salts and reduces toxicity. Like other iodinated contrast agents, it may cause allergic reactions or kidney stress and requires careful screening of patients.
Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.
Yes, Iodamide Meglumine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201172. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 29182. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="iodamide-meglumine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/iodamide-meglumine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/iodamide-meglumine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/iodamide-meglumine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="iodamide-meglumine"></drugfyi-drug>